Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
123.76
+1.18 (0.97%)
Sep 16, 2025, 1:44 PM EDT
Novartis AG Employees
Novartis AG had 75,883 employees as of December 31, 2024. The number of employees decreased by 174 or -0.23% compared to the previous year.
Employees
75,883
Change (1Y)
-174
Growth (1Y)
-0.23%
Revenue / Employee
$727,251
Profits / Employee
$179,935
Market Cap
238.00B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 75,883 | -174 | -0.23% |
| Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
| Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
| Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
| Dec 31, 2020 | 105,794 | 1,880 | 1.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Novartis AG News
- 4 days ago - Novartis Catches a ‘Sell.' Goldman Sachs Says the Stock Is Overvalued. - Barrons
- 4 days ago - Goldman Sachs Downgrades Novartis (NVS) to Sell Over Risk Concerns - GuruFocus
- 4 days ago - Novartis cut to Sell at Goldman Sachs on near-term risks - Seeking Alpha
- 4 days ago - This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
- 4 days ago - Novartis (NVS) Downgraded to Sell by Goldman Sachs | NVS Stock News - GuruFocus
- 6 days ago - US tariffs, pricing risks to be manageable for Big Pharma, Morningstar says - Reuters
- 7 days ago - Buyout Of Tourmaline By Novartis Primarily On Pacibekitug IL-6 Novel Mode Of Action - Seeking Alpha
- 7 days ago - Novartis Buys Tourmaline Bio in $1.4 Billion Heart Drug Deal(edit) - GuruFocus